BioPharma Resources

Investigational drug · Phase 3

TQA3605

Not approved by FDA. In 3 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Chronic Hepatitis b, Chronic Hepatitis B, HBV Infection With LLV.

Phase 3

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

3

2 still active

All registered trials

4

Any phase or sponsor naming "TQA3605"

First trial start

2023

Dec 7, 2023

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "TQA3605", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Chronic Hepatitis b
  • Chronic Hepatitis B
  • HBV Infection With LLV

Approved drugs for the same conditions: Hepatitis B · Infectious disease and vaccines

Largest trials

Live from ClinicalTrials.gov: studies naming "TQA3605" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 0 on PubMed

No PubMed records name it yet, which is common for early code-named drugs.

Also in development for Chronic Hepatitis b

  • GST-HG141Phase 33 trials

    Fujian Akeylink Biotechnology Co., Ltd. · Chronic Hepatitis b, Chronic Hepatitis B

  • TAFPhase 33 trials

    Gilead Sciences · HIV-1-infection, Chronic Hepatitis B

  • HRS-5635Phase 32 trials

    Fujian Shengdi Pharmaceutical Co., Ltd. · Chronic Hepatitis B, Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B

  • Peg-IFN-αpegylated interferonPhase 26 trials

    Brii Biosciences Limited · Chronic Hepatitis B, Chronic Hepatitis B Virus (HBV) Infection, Hepatitis B, Chronic

  • TVAX-008Phase 24 trials

    Grand Theravac Life Sciences (Nanjing) Co., Ltd. · Chronic Hepatitis B, HBV Infection, Chronic Hepatitis B Virus

  • HT-101Phase 23 trials

    Suzhou HepaThera Biotech Co., Ltd. · Chronic Hepatitis B, Chronic Hepatitis B Virus Infection

  • HT-102Phase 23 trials

    Suzhou HepaThera Biotech Co., Ltd. · Chronic Hepatitis B, Chronic Hepatitis B Virus Infection

  • NAsNucleoside analogs, acidPhase 23 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chronic Hepatitis B, HBV Infection With LLV

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.